FinancialVu

Market News and Views

You are here: Home / Top Stories / : FDA approves treatment for people with mild forms of Alzheimer’s

: FDA approves treatment for people with mild forms of Alzheimer’s

by

Leqembi, which was developed by Eisai and Biogen, will cost about $26,000 a year